Our Mission and what we do
Dr. Gil Morgan (Director of the Network)
Originally from Texas but due to all the strange turns of life ended moving and practicing medicine in Sweden for about a decade. Main areas of interest are Clinical Oncology, Lung Cancer, Cancer Prevention and Targeted Therapeutics.
Originally from Texas but due to all the strange turns of life ended moving and practicing medicine in Sweden for about a decade. Main areas of interest are Clinical Oncology, Lung Cancer, Cancer Prevention and Targeted Therapeutics.
Our OncoAlert Faculty & Strongest Supporters
Dr. Toni Choueiri
Dr. Choueiri is the Director of the Lank Center for Genitourinary (GU) Oncology at Dana-Farber Cancer Institute and Professor of Medicine at Harvard Medical School. He is the Co-Leader of the Kidney Cancer Program at Dana-Farber/Harvard Cancer Center and President of the Medical Staff at Dana-Farber. He serves on the National Comprehensive Cancer Network (NCCN) Kidney Cancer Panel, the GU Steering Committee (GUSC) Task Force of the National Cancer Institute (NCI), and is Chairman of the Medical and Scientific Steering Committee of the Kidney Cancer Association.
Dr. Choueiri is the Director of the Lank Center for Genitourinary (GU) Oncology at Dana-Farber Cancer Institute and Professor of Medicine at Harvard Medical School. He is the Co-Leader of the Kidney Cancer Program at Dana-Farber/Harvard Cancer Center and President of the Medical Staff at Dana-Farber. He serves on the National Comprehensive Cancer Network (NCCN) Kidney Cancer Panel, the GU Steering Committee (GUSC) Task Force of the National Cancer Institute (NCI), and is Chairman of the Medical and Scientific Steering Committee of the Kidney Cancer Association.
Dr. Julie R Gralow
Dr. Gralow is the Chief Medical Officer (CMO) and Executive Vice President of ASCO, and brings to her role deep expertise in patient care, research, education, and global health.
Dr. Gralow is the Chief Medical Officer (CMO) and Executive Vice President of ASCO, and brings to her role deep expertise in patient care, research, education, and global health.
Dr. Solange Peters
Dr. Peters is President of the European Society for Medical Oncology
She is also currently in charge of teaching and patient care in the area of medical oncology and thoracic malignancies at the Department of Oncology of Lausanne University.
Dr. Peters is President of the European Society for Medical Oncology
She is also currently in charge of teaching and patient care in the area of medical oncology and thoracic malignancies at the Department of Oncology of Lausanne University.
Dr. Lena Sharp
Dr. Sharp is the past President of the European Oncology Nurses Society. Head of the Regional Cancer Center, Stockholm, Sweden. She was previously the Chief Nursing Officer and Patient Safety Coordinator at the Department of Oncology, Karolinska University Hospital and has a long experience in cancer nursing, clinical work, leadership, teaching and research. Lena main research focus is Health Care Communication and Patient Safety. Lena has a Ph D from Karolinska Institute.
Dr. Sharp is the past President of the European Oncology Nurses Society. Head of the Regional Cancer Center, Stockholm, Sweden. She was previously the Chief Nursing Officer and Patient Safety Coordinator at the Department of Oncology, Karolinska University Hospital and has a long experience in cancer nursing, clinical work, leadership, teaching and research. Lena main research focus is Health Care Communication and Patient Safety. Lena has a Ph D from Karolinska Institute.
Dr. Andrés Cervantes
Incoming President of the European Society for Medical Oncology
Professor of Medicine at the University of Valencia, Spain.
Dr. Cervantes serves as Head of the Department of Medical Oncology at the University Hospital in Valencia
- Dr. Jonathan Trent
Dr. Hope Rugo
Dr. Rugo is a professor of medicine in the Division of Hematology and Oncology at the University of California San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center, where she is also the director of Breast Oncology and Clinical Trials Education.
Dr. Christoph Zielinski
Professor Zielinski is Director of the Vienna Cancer Center (VCC) which coordinates cancer care and clinical trials within the City of Vienna. |
Dr. Yelena Janjigian
medical oncologist and Chief of the Gastrointestinal Oncology Service at Memorial Sloan Kettering Cancer Center. She specializes in the treatment of malignancies of the gastrointestinal tract, including esophagus and stomach cancers.
medical oncologist and Chief of the Gastrointestinal Oncology Service at Memorial Sloan Kettering Cancer Center. She specializes in the treatment of malignancies of the gastrointestinal tract, including esophagus and stomach cancers.
Dr. Don Dizon
oncologist who specializes in women's cancers. He is the director of women's cancers at Lifespan Cancer Institute and director of medical oncology at Rhode Island Hospital. He is also a professor of medicine at The Warren Alpert Medical School of Brown University.
oncologist who specializes in women's cancers. He is the director of women's cancers at Lifespan Cancer Institute and director of medical oncology at Rhode Island Hospital. He is also a professor of medicine at The Warren Alpert Medical School of Brown University.
Dr. Darcy Burbage
Director at Large at Oncology Nursing Society
Oncology Clinical Nurse specialist & Oncology Nursing Advocate
Director at Large at Oncology Nursing Society
Oncology Clinical Nurse specialist & Oncology Nursing Advocate
Dr. Neeraj Agarwal
Profesor of medicine/physician and an investigator at the Huntsman Cancer Institute (HCI), University of Utah. At the HCI, he directs the Genitourinary Oncology (GU) Program, the Center of Investigational Therapeutics (CIT), co-leads the Experimental Therapeutic Program (one of the four cancer center support grant programs at the HCI), and serves on the cabinet of the Director of HCI.
Profesor of medicine/physician and an investigator at the Huntsman Cancer Institute (HCI), University of Utah. At the HCI, he directs the Genitourinary Oncology (GU) Program, the Center of Investigational Therapeutics (CIT), co-leads the Experimental Therapeutic Program (one of the four cancer center support grant programs at the HCI), and serves on the cabinet of the Director of HCI.
Dr. Christine Lovly
- Associate Professor of Medicine at Vanderbilt University. Her research involves the development of novel treatment strategies for ALK positive lung cancer.
Dr. Charles Swanton
Professor Charles Swanton FRCP BSc PhD is a clinician scientist, focusing his work on understanding the challenges inherent in the management of metastatic cancer and their drug resistant and incurable nature.
Dr. Fumiko Chino
Dr. Chino is a radiation oncologist at Memorial Sloan-Kettering Cancer Center, describes to host Jack West the impact of a mother as a successful radiation oncologist, & the many struggles of serving as a caregiver to a young adult spouse with cancer.
Dr. Chino is a radiation oncologist at Memorial Sloan-Kettering Cancer Center, describes to host Jack West the impact of a mother as a successful radiation oncologist, & the many struggles of serving as a caregiver to a young adult spouse with cancer.
Dr. Matteo Lambertini
Dr. Lambertini is an adjunct professor and consultant in medical oncology at the IRCCS Policlinico San Martino Hospital – University of Genova in Genova (Italy). He is mainly focused in the care of breast cancer patients and is deeply involved in breast cancer research.
Dr. Lambertini is an adjunct professor and consultant in medical oncology at the IRCCS Policlinico San Martino Hospital – University of Genova in Genova (Italy). He is mainly focused in the care of breast cancer patients and is deeply involved in breast cancer research.
Ginny Mason RN
Nurse Mason is the Executive Director of the Inflammatory Breast Cancer Research Foundation (ibcRF), a grassroots advocacy organization dedicated to advancing inflammatory breast cancer (IBC) research as well as increasing awareness of IBC in the medical and lay communities.
Nurse Mason is the Executive Director of the Inflammatory Breast Cancer Research Foundation (ibcRF), a grassroots advocacy organization dedicated to advancing inflammatory breast cancer (IBC) research as well as increasing awareness of IBC in the medical and lay communities.
Dr . Aleix Prat
Head of the Medical Oncology Department of the Hospital Clínic Barcelona (Spain), Associate Professor at the University of Barcelona and Head of the Translational Genomics and Targeted Therapeutics in Solid Tumors Lab at IDIBAPS.
Head of the Medical Oncology Department of the Hospital Clínic Barcelona (Spain), Associate Professor at the University of Barcelona and Head of the Translational Genomics and Targeted Therapeutics in Solid Tumors Lab at IDIBAPS.
Dr. Erika Hamilton
Dr. Hamilton cares for patients with breast and gynecologic cancer. As the director of the breast cancer and gynecologic cancer research program at Sarah Cannon Research Institute, she oversees the program and the clinical trial menu for these cancers across the Sarah Cannon network.
Dr. Hamilton cares for patients with breast and gynecologic cancer. As the director of the breast cancer and gynecologic cancer research program at Sarah Cannon Research Institute, she oversees the program and the clinical trial menu for these cancers across the Sarah Cannon network.
Dr. Hans Hammers
Oncologist in Dallas, Texas, affiliated with University of Texas Southwestern Medical Center
Leaders in Kidney Cancer Research
Oncologist in Dallas, Texas, affiliated with University of Texas Southwestern Medical Center
Leaders in Kidney Cancer Research
Dr. Lecia Sequist
Dr. Sequist is a medical oncologist at the Massachusetts General Hospital Cancer Center, associate professor of medicine at Harvard Medical School & a member of the LUNGevity Foundation Scientific Advisory Board
Dr. Sequist is a medical oncologist at the Massachusetts General Hospital Cancer Center, associate professor of medicine at Harvard Medical School & a member of the LUNGevity Foundation Scientific Advisory Board
Dr. Evandro de Azambuja
Evandro de Azambuja, MD, PhD, is the Head of the Medical Support Team (Academic Promoting Team) located at the Jules Bordet Institute in Brussels, Belgium.
Evandro de Azambuja, MD, PhD, is the Head of the Medical Support Team (Academic Promoting Team) located at the Jules Bordet Institute in Brussels, Belgium.
Dr. Helena Ullgren
Specialist Nurse Oncology and palliative care, PhD
Karolinska University Hospital
President Elect of European Oncology Nurses Society
Specialist Nurse Oncology and palliative care, PhD
Karolinska University Hospital
President Elect of European Oncology Nurses Society
Dr. Mark Lewis
Dr. Lewis is the Director of Gastrointestinal Oncology,
Intermountain Healthcare. Intermountain Medical Oncology
Dr. Lewis is the Director of Gastrointestinal Oncology,
Intermountain Healthcare. Intermountain Medical Oncology
Dr. Maryam Lustberg
Medical Oncologist specialising in breast cancer & Survivorship.
Dr. Lustberg is the incoming president of MASCC.
Medical Oncologist specialising in breast cancer & Survivorship.
Dr. Lustberg is the incoming president of MASCC.
Dr. Vivek Subbiah
Dr. Subbiah is a clinical trialist and Physician Investigator in the Department of Investigational Cancer Therapeutics at MD Anderson, which is the largest oncology drug development unit in the world.
Dr. Subbiah is a clinical trialist and Physician Investigator in the Department of Investigational Cancer Therapeutics at MD Anderson, which is the largest oncology drug development unit in the world.
Dr. Sherene Loi
Medical Oncologist specialised in breast cancer treatment as well as clinician scientist with expertise in genomics, immunology and drug development. Her work is focused on developing new therapeutic approaches that may improve outcomes of breast cancer patients.
Medical Oncologist specialised in breast cancer treatment as well as clinician scientist with expertise in genomics, immunology and drug development. Her work is focused on developing new therapeutic approaches that may improve outcomes of breast cancer patients.
Dr. Icro Meattini
Doctor Meattini is an Associate Professor at the Department of Clinical and Experimental Biomedical Sciences of the University of Florence (Florence, Italy), Icro Meattini works as Clinical Oncologist since 2011 at the Radiation Oncology Unit of the Oncology Department at the Florence University Hospital, where is responsible for the Outpatient Clinics Unit, Clinical Trials Unit, and leader of the Clinical Oncology Group of the Breast Cancer Multidisciplinary Team. Active member of the European Society for Radiation Oncology (ESTRO), the European Organisation for Research and Treatment of Cancer (EORTC), and the Italian Association for Radiation and Clinical Oncology (AIRO).
Doctor Meattini is an Associate Professor at the Department of Clinical and Experimental Biomedical Sciences of the University of Florence (Florence, Italy), Icro Meattini works as Clinical Oncologist since 2011 at the Radiation Oncology Unit of the Oncology Department at the Florence University Hospital, where is responsible for the Outpatient Clinics Unit, Clinical Trials Unit, and leader of the Clinical Oncology Group of the Breast Cancer Multidisciplinary Team. Active member of the European Society for Radiation Oncology (ESTRO), the European Organisation for Research and Treatment of Cancer (EORTC), and the Italian Association for Radiation and Clinical Oncology (AIRO).
Dr. Stephen V. Liu
Dr. Stephen V. Liu is an Assistant Professor of Medicine and a practicing thoracic medical oncologist at the Lombardi Comprehensive Cancer Center at Georgetown University.
Dr. Stephen V. Liu is an Assistant Professor of Medicine and a practicing thoracic medical oncologist at the Lombardi Comprehensive Cancer Center at Georgetown University.
Dr. Elisabeth de Vries
Professor of Medical Oncology at the University Medical Center Groningen, Groningen, the Netherlands. She is involved in patient care, teaching, and research. Her focus is on interdisciplinary, translational research, aiming for personalized medicine.
Professor of Medical Oncology at the University Medical Center Groningen, Groningen, the Netherlands. She is involved in patient care, teaching, and research. Her focus is on interdisciplinary, translational research, aiming for personalized medicine.
Dr. Gilberto Lopes
Dr. Lopes is a medical oncologist, is medical director for international programs and associate director for global oncology at the Sylvester Comprehensive Cancer Center and associate professor of clinical medicine at the University of Miami in Florida.
Dr. Lopes is a medical oncologist, is medical director for international programs and associate director for global oncology at the Sylvester Comprehensive Cancer Center and associate professor of clinical medicine at the University of Miami in Florida.
Janet Freeman-Daily
Patient Advocate and a 4+ year NSCLC survivor, “kept alive,” as she says, by clinical trials. In her previous career, Janet was an aerospace systems engineer where, among other things, she learned to be a technical translator. She now brings that same experience and science to lung cancer writing, blogging, public speaking, as well as collaborating with other patients, care partners, advocates, healthcare providers and researchers.
Patient Advocate and a 4+ year NSCLC survivor, “kept alive,” as she says, by clinical trials. In her previous career, Janet was an aerospace systems engineer where, among other things, she learned to be a technical translator. She now brings that same experience and science to lung cancer writing, blogging, public speaking, as well as collaborating with other patients, care partners, advocates, healthcare providers and researchers.
Dr. Fabrice Barlesi
General Director of Gustave Roussy
Doctor Barlesi is a Professor of Medicine at the University of Aix-Marseille. He has been head of the Multidisciplinary Oncology and Innovative Therapies Department of the Nord Hospital in Marseille (Marseille Public Hospitals) and the Marseille Centre for Early Trials in Oncology (CLIP2) which were established by him
General Director of Gustave Roussy
Doctor Barlesi is a Professor of Medicine at the University of Aix-Marseille. He has been head of the Multidisciplinary Oncology and Innovative Therapies Department of the Nord Hospital in Marseille (Marseille Public Hospitals) and the Marseille Centre for Early Trials in Oncology (CLIP2) which were established by him
Julia Maues
Julia is a metastatic breast cancer survivor and advocate, committed to contributing with patients, researchers, clinicians, drugmakers, and other stakeholders to improve the lives of women and men affected by the disease.
CoCreator of GRASP
Julia is a metastatic breast cancer survivor and advocate, committed to contributing with patients, researchers, clinicians, drugmakers, and other stakeholders to improve the lives of women and men affected by the disease.
CoCreator of GRASP
Dr. Jack West
Executive Director of Employer Strategy; Associate Clinical Professor, Department of Medical Oncology & Therapeutics Research. City of Hope
Executive Director of Employer Strategy; Associate Clinical Professor, Department of Medical Oncology & Therapeutics Research. City of Hope
Dr. Miriam Knoll
Radiation Oncologist, Forbes Health Contributor, JOWMA President. Advanced Radiation Oncology Services at Montefiore Nyack Hospital, New York
Radiation Oncologist, Forbes Health Contributor, JOWMA President. Advanced Radiation Oncology Services at Montefiore Nyack Hospital, New York
Dr. Brendon Stiles
Cardiothoracic surgeon at NewYork-Presbyterian/Weill Cornell Medical Center
Dr. Stiles is the chair of the Lung Cancer Research Foundation's board directors
Cardiothoracic surgeon at NewYork-Presbyterian/Weill Cornell Medical Center
Dr. Stiles is the chair of the Lung Cancer Research Foundation's board directors
Dr. Sara Tolaney
Dr. Tolaney is an Assistant Professor of Medicine at Harvard Medical School and Associate Director for the Susan F Smith Center for Women’s Cancers at Dana-Farber/Brigham and Women's Cancer Center.
Dr. Tolaney is an Assistant Professor of Medicine at Harvard Medical School and Associate Director for the Susan F Smith Center for Women’s Cancers at Dana-Farber/Brigham and Women's Cancer Center.
Dr. Andreas Charalambous
Dr. Andreas Charalambous, RN, PhD (Oncology Nursing), has a clinical background in cancer care and has worked clinically and academically in Cyprus, U.K and Finland. He holds an Assistant Professor’s position of Oncology and Palliative Care at the Cyprus University of Technology and a Docent’s position at University of Turku (Finland). He is an EONS Executive Board Member since 2013 and was elected as President-Elect in 2017.
Dr. Andreas Charalambous, RN, PhD (Oncology Nursing), has a clinical background in cancer care and has worked clinically and academically in Cyprus, U.K and Finland. He holds an Assistant Professor’s position of Oncology and Palliative Care at the Cyprus University of Technology and a Docent’s position at University of Turku (Finland). He is an EONS Executive Board Member since 2013 and was elected as President-Elect in 2017.
Dr. Narjust Duma
Doctor Duma is a faculty member in the Division of Hematology, Medical Oncology and Palliative Care. She is a medical oncologist with clinical and research focus on thoracic malignancies.
Co Founder of Latinas in medicine
Doctor Duma is a faculty member in the Division of Hematology, Medical Oncology and Palliative Care. She is a medical oncologist with clinical and research focus on thoracic malignancies.
Co Founder of Latinas in medicine
Dr. Fabrice André
Fabrice André MD, PhD, is an oncologist based at Gustave Roussy Cancer Cancer, Villejuif, France. He is Professor of Medicine at University Paris Saclay. His BCRF research focuses on the characterisation of molecular alterations in metastatic breast cancers.
Fabrice André MD, PhD, is an oncologist based at Gustave Roussy Cancer Cancer, Villejuif, France. He is Professor of Medicine at University Paris Saclay. His BCRF research focuses on the characterisation of molecular alterations in metastatic breast cancers.
Dr. Anne Marie Baird
president of Lung Cancer Europe (LuCE). LuCE is a non-profit umbrella organization that aims to provide a voice for people impacted by lung cancer in Europe.
Doctor Baird is a molecular biologist with research interests in inflammation, epigenetics, drug resistance and disease biomarkers. She is currently a Research Fellow in Trinity College Dublin and a Visiting Research Fellow in Queensland University of Technology.
president of Lung Cancer Europe (LuCE). LuCE is a non-profit umbrella organization that aims to provide a voice for people impacted by lung cancer in Europe.
Doctor Baird is a molecular biologist with research interests in inflammation, epigenetics, drug resistance and disease biomarkers. She is currently a Research Fellow in Trinity College Dublin and a Visiting Research Fellow in Queensland University of Technology.
Dr. Sumanta Pal
Internationally recognized leader in the area of genitourinary cancers, including kidney, bladder, and prostate cancers. He is co-director of City of Hope's Kidney Cancer Program and is the head of the kidney and bladder cancer disease team at the institution.
Internationally recognized leader in the area of genitourinary cancers, including kidney, bladder, and prostate cancers. He is co-director of City of Hope's Kidney Cancer Program and is the head of the kidney and bladder cancer disease team at the institution.
Dr. Stephanie Graff
Doctor Graff is a medical oncology specialist in Overland Park, KS. She currently practices at Sarah Cannon Cancer Institute at Menorah Medical Center and is affiliated with Research Medical Center.
Doctor Graff is a medical oncology specialist in Overland Park, KS. She currently practices at Sarah Cannon Cancer Institute at Menorah Medical Center and is affiliated with Research Medical Center.
Dr. Ravindran Kanesvaran
Doctor Kanesvaran is a Senior Consultant and Deputy Head of the Division of Medical Oncology of the National Cancer Centre Singapore and Medical Director of NCCS@ SKH Oncology. He is also an Associate Professor at Duke-NUS Medical School and clinical senior lecturer at the Yong Loo Lin School of Medicine, National University of Singapore. He is actively involved in graduate medical education and is the Program Director of the Medical Oncology Senior Residency Program.
Doctor Kanesvaran is a Senior Consultant and Deputy Head of the Division of Medical Oncology of the National Cancer Centre Singapore and Medical Director of NCCS@ SKH Oncology. He is also an Associate Professor at Duke-NUS Medical School and clinical senior lecturer at the Yong Loo Lin School of Medicine, National University of Singapore. He is actively involved in graduate medical education and is the Program Director of the Medical Oncology Senior Residency Program.
Dr. Pilar Garrido
Doctor Garrido is Associate Professor of Medical Oncology at Universidad de Alcalá and serves as Head of the Thoracic Tumours Section in the Medical Oncology Department at the University Hospital Ramón y Cajal in Madrid, Spain.
Doctor Garrido is Associate Professor of Medical Oncology at Universidad de Alcalá and serves as Head of the Thoracic Tumours Section in the Medical Oncology Department at the University Hospital Ramón y Cajal in Madrid, Spain.
Dr. Daniel Heng
Dr. Heng is a Staff Medical Oncologist at the Tom Baker Cancer Center in Calgary. Alberta and a Clinical Professor of Medicine at the University of Calgary .
Dr. Heng is a Staff Medical Oncologist at the Tom Baker Cancer Center in Calgary. Alberta and a Clinical Professor of Medicine at the University of Calgary .
Dr. Marina Garassino
Dr. Garassino is the head of the thoracic oncology unit at the National Cancer Institute of Milan, where her principle area of research is thoracic malignancies (lung cancer, mesothelioma, thymic malignancies).
Dr. Garassino is the head of the thoracic oncology unit at the National Cancer Institute of Milan, where her principle area of research is thoracic malignancies (lung cancer, mesothelioma, thymic malignancies).
Dr. Petros Grivas
Dr. Grivas is a board-certified medical oncologist who specializes in treating patients with genitourinary cancers, such as bladder cancer and prostate cancer.
Dr. Grivas serves as the director of University of Washington Medicine’s Genitourinary Cancers Program, giving frequent lectures, educating other oncologists and trainees and publishing novel research. He also conducts clinical trials, one of which led to the FDA approval of new drugs for bladder and urothelial cancer.
Dr. Grivas is a board-certified medical oncologist who specializes in treating patients with genitourinary cancers, such as bladder cancer and prostate cancer.
Dr. Grivas serves as the director of University of Washington Medicine’s Genitourinary Cancers Program, giving frequent lectures, educating other oncologists and trainees and publishing novel research. He also conducts clinical trials, one of which led to the FDA approval of new drugs for bladder and urothelial cancer.
Dr. Cathy Eng
Medical Oncology Specialist at the Vanderbilt-Ingram Cancer Center.
Doctor Eng is a Professor of Medicine, Hematology and Oncology, and is the Co-Director of GI Oncology and Co-Leader of the Gastrointestinal Cancer Research Program.
Medical Oncology Specialist at the Vanderbilt-Ingram Cancer Center.
Doctor Eng is a Professor of Medicine, Hematology and Oncology, and is the Co-Director of GI Oncology and Co-Leader of the Gastrointestinal Cancer Research Program.
Dr. Pashtoon Kasi
Doctor Kasi is a Clinical Assistant Professor of Internal Medicine - Hematology, Oncology and Blood and Marrow Transplantation. His research interests are in gastrointestinal cancers with a recent primary focus on colorectal cancers.
Doctor Kasi is a Clinical Assistant Professor of Internal Medicine - Hematology, Oncology and Blood and Marrow Transplantation. His research interests are in gastrointestinal cancers with a recent primary focus on colorectal cancers.
Dr. Andrea Apolo
Doctor Apolo is a meedical oncologist specialized in bladder cancer research. She is an investigator in the NCI's GU malignancies branch and head of the bladder cancer section.
Doctor Apolo is a meedical oncologist specialized in bladder cancer research. She is an investigator in the NCI's GU malignancies branch and head of the bladder cancer section.
Dr. Sanjay Popat
Doctor Popat is a Professor & Consultant Thoracic Medical Oncologist at The Royal Marsden and Honorary Clinical Senior Lecturer in the Molecular Genetics and Genomics Group at the National Heart and Lung Institute, Imperial College London.
Doctor Popat is a Professor & Consultant Thoracic Medical Oncologist at The Royal Marsden and Honorary Clinical Senior Lecturer in the Molecular Genetics and Genomics Group at the National Heart and Lung Institute, Imperial College London.
Ivy Elkins
Ivy is a Lung Cancer Patient Advocatehas served as a consumer reviewer for the Department of Defense Lung Cancer Research Program, completed the AACR Scientist-Survivor program, acted as faculty for the ASCO/AACR Methods in Clinical Cancer Research Workshop, and participated in the program committee for IASLC’s Chicago Multidisciplinary Symposium in Thoracic Oncology.
CoFounder of EGFRResisters
Ivy is a Lung Cancer Patient Advocatehas served as a consumer reviewer for the Department of Defense Lung Cancer Research Program, completed the AACR Scientist-Survivor program, acted as faculty for the ASCO/AACR Methods in Clinical Cancer Research Workshop, and participated in the program committee for IASLC’s Chicago Multidisciplinary Symposium in Thoracic Oncology.
CoFounder of EGFRResisters
Johan de Munter RN
Assistant Nurse Manager Cancer Center, University Hospital Ghent & President-Elect, European Oncology Nursing Society
Assistant Nurse Manager Cancer Center, University Hospital Ghent & President-Elect, European Oncology Nursing Society
Dr. Charu Aggarwal
Doctor Aggarwal is the Leslye Heisler Assistant Professor of Medicine in the Hematology-Oncology Division at the University of Pennsylvania’s Perelman School of Medicine. She is an active member of the Abramson Cancer Center (ACC) where she serves as Physician Leader for the clinical research program for Airways Malignancies.
Doctor Aggarwal is the Leslye Heisler Assistant Professor of Medicine in the Hematology-Oncology Division at the University of Pennsylvania’s Perelman School of Medicine. She is an active member of the Abramson Cancer Center (ACC) where she serves as Physician Leader for the clinical research program for Airways Malignancies.
Dr. Ben Solomon
Doctor Solomon is a medical oncologist & Professor in the Lung Service and the Head & Neck service at Peter Mac in Australia. He is the Group Leader of the Molecular Therapeutics and Biomarkers Laboratory in the Research Division.
Doctor Solomon is a medical oncologist & Professor in the Lung Service and the Head & Neck service at Peter Mac in Australia. He is the Group Leader of the Molecular Therapeutics and Biomarkers Laboratory in the Research Division.
Jill Feldman
Jill Feldman is a lung cancer patient and activist.
Jill was a volunteer, an advocate and past president of LUNGevity.
CoFounder of EGFRResisters
Jill Feldman is a lung cancer patient and activist.
Jill was a volunteer, an advocate and past president of LUNGevity.
CoFounder of EGFRResisters
Dr. Anirban Maitra
Doctor Maitra, is the scientific director of the Pancreatic Cancer Research Center at MD Anderson and co-leader of the Pancreatic Cancer Moon Shot
Doctor Maitra, is the scientific director of the Pancreatic Cancer Research Center at MD Anderson and co-leader of the Pancreatic Cancer Moon Shot
Diane Mapes
Diane is a Patient advocate and a writer for Fred Hutchinson Cancer Research Center covering research, public health, prevention, health disparities and the patient experience.
Diane is a Patient advocate and a writer for Fred Hutchinson Cancer Research Center covering research, public health, prevention, health disparities and the patient experience.
Dr. Christian Rolfo
Doctor Rolfo is the director of the Thoracic Medical Oncology and the Early Clinical Trials at the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC). He specializes in thoracic oncology, drug development and translational oncology.
Doctor Rolfo is the director of the Thoracic Medical Oncology and the Early Clinical Trials at the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC). He specializes in thoracic oncology, drug development and translational oncology.
Dr. Katsuki Arima
Doctor Arima is a medical Oncologist in Brazil with a focus on breast cancer
She is also the Chief editor of OncoAlert Facebook
Doctor Arima is a medical Oncologist in Brazil with a focus on breast cancer
She is also the Chief editor of OncoAlert Facebook
Dr. Kelly Shanahan
Doctor Shanahan is a retired OBGYN and a Metastatic Breast Cancer Patient Advocate
Doctor Shanahan is a retired OBGYN and a Metastatic Breast Cancer Patient Advocate
Dr. Umberto Malapelle
Doctor Malapelle is the Chief Supervisor of Predictive Molecular Pathology Laboratory, of the University of Naples Federico II. He was appointed in December 2015 Assistant Professor in Anatomic Pathology in School of Medicine, University of Naples Federico II.
Currently his main research interest is in the field of genomic biomarkers validation and testing for predictive information in the field of lung cancer, metastatic colorectal cancer, melanoma and gastrointestinal stromal tumor.
Doctor Malapelle is the Chief Supervisor of Predictive Molecular Pathology Laboratory, of the University of Naples Federico II. He was appointed in December 2015 Assistant Professor in Anatomic Pathology in School of Medicine, University of Naples Federico II.
Currently his main research interest is in the field of genomic biomarkers validation and testing for predictive information in the field of lung cancer, metastatic colorectal cancer, melanoma and gastrointestinal stromal tumor.
Dr. Nicole Kuderer
Doctor Kuderer is Faculty, Division of Hematology, Department of Medicine, University of Washington Medical Center. Duke Comprehensive Cancer Center.
Doctor Kuderer is Faculty, Division of Hematology, Department of Medicine, University of Washington Medical Center. Duke Comprehensive Cancer Center.
Dr. Philippe Aftimos
Doctor Aftimos is a Medical Oncologist, Clinical Trials Development Leader at Institut Jules Bordet in Brussels, Belgium.
Doctor Aftimos is a Medical Oncologist, Clinical Trials Development Leader at Institut Jules Bordet in Brussels, Belgium.
Dee Sparcio
Ovarian Cancer survivor and Patient Advocate
Ovarian Cancer survivor and Patient Advocate
Dr. Giuseppe Curigliano
Associate Professor of Medical Oncology at the University of Milano and the Head of the Division of Early Drug Development at the European Institute of Oncology, IRCCS, Italy.
Associate Professor of Medical Oncology at the University of Milano and the Head of the Division of Early Drug Development at the European Institute of Oncology, IRCCS, Italy.
Dr. Jesus Anampa
Doctor Anampa is an Assistant Professor of Clinical Medicine in the Department of Medical Oncology at Albert Einstein College of Medicine/ Montefiore Medical Center.
Doctor Anampa is an Assistant Professor of Clinical Medicine in the Department of Medical Oncology at Albert Einstein College of Medicine/ Montefiore Medical Center.
Dr. Mariana Brandao
Doctor Brandao is a Medical Oncologist in Brussels Belgium at Institut Jules Bordet focusing on Lung Cancer
Doctor Brandao is a Medical Oncologist in Brussels Belgium at Institut Jules Bordet focusing on Lung Cancer
Dr. Bartomeu Massuti
Head of the department of medical oncology at Alicante University Hospital and associate professor at the Universidad Miguel Hernandez de Elche. Focus on Thoracic Oncology
Head of the department of medical oncology at Alicante University Hospital and associate professor at the Universidad Miguel Hernandez de Elche. Focus on Thoracic Oncology
Dr. Bettina Ryll
Doctor Ryll is A Cancer Misson Board member at the European Commission, Founder of the Melanoma Patient Network Europe and, until December 2018, Chair of the ESMO Patient Advocates Working Group.
Doctor Ryll is A Cancer Misson Board member at the European Commission, Founder of the Melanoma Patient Network Europe and, until December 2018, Chair of the ESMO Patient Advocates Working Group.
Dr. Percy Lee
Professor and Section Chief of the Thoracic Radiation Oncology Section in the Department of Radiation Oncology at The University of Texas M.D. Anderson Cancer Center.
Professor and Section Chief of the Thoracic Radiation Oncology Section in the Department of Radiation Oncology at The University of Texas M.D. Anderson Cancer Center.
Dr. Tian Zhang
Assistant Professor of Medicine. Member of the Duke Cancer Institute.
Focus on GU Oncology
Assistant Professor of Medicine. Member of the Duke Cancer Institute.
Focus on GU Oncology
Dr. Manju George
Doctor George is a Patient Advocate with post-doctoral training and research experience in Cell and Cancer Biology and is the Scientific Director at Colontown/Paltown
Doctor George is a Patient Advocate with post-doctoral training and research experience in Cell and Cancer Biology and is the Scientific Director at Colontown/Paltown
Ms Janice Cowden
Research patient advocate living w/ Stage IV Metastatic Breast Cancer.
Research patient advocate living w/ Stage IV Metastatic Breast Cancer.
Ms Patty Spears
Research Manager, Patient Advocates for Research Council
Office of Clinical & Translational Research in Oncology
Patty Spears provides scientific leadership and guidance to advance OCTR translational trials and data management of the Alliance for Clinical Trials in Oncology breast cancer research trials.
UNC Cancer Center
Research Manager, Patient Advocates for Research Council
Office of Clinical & Translational Research in Oncology
Patty Spears provides scientific leadership and guidance to advance OCTR translational trials and data management of the Alliance for Clinical Trials in Oncology breast cancer research trials.
UNC Cancer Center
